Implementation of a comprehensive smoking cessation program in cancer care.
Smoking cessation
health care providers
implementation
patient education
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
entrez:
4
1
2020
pubmed:
4
1
2020
medline:
17
7
2020
Statut:
ppublish
Résumé
Quitting smoking after a cancer diagnosis maximizes treatment-related effects, improves prognosis, and enhances quality of life. However, smoking cessation (sc) services are not routinely integrated into cancer care. The Princess Margaret Cancer Centre implemented a digitally-based sc program in oncology, leveraging an e-referral system (cease) to screen all new ambulatory patients, provide tailored education and advice on quitting, and facilitate referrals. We adopted the Framework for Managing eHealth Change to guide implementation of the sc program by integrating 6 key elements: governance and leadership, stakeholder engagement, communication, workflow analysis and integration, monitoring and evaluation, and training and education. Incorporating elements of the Framework, we used extensive stakeholder engagement and strategic partnerships to establish a sc program with organizational and provincial accountability. Existing electronic patient-reported assessments were changed to integrate cease. Clinic audits and staff engagement allowed for analysis of workflow, ongoing monitoring and evaluation that aided in establishing a communication strategy, and development of cancer-specific education for patients and health care providers. From April 2016 to March 2018, 22,137 new patients were eligible for screening. Among those new patients, 13,617 (62%) were screened, with 1382 (10%) being current smokers and 532 (4%) having recently quit (within 6 months). Of the current smokers and those who had recently quit, all were advised to quit or to stay smoke-free, and 380 (20%) accepted referral to a sc counselling service. Here, we provide a comprehensive practice blueprint for the implementation of digitally based sc programs as a standard of care within comprehensive cancer centres with high patient volumes.
Sections du résumé
Background
Quitting smoking after a cancer diagnosis maximizes treatment-related effects, improves prognosis, and enhances quality of life. However, smoking cessation (sc) services are not routinely integrated into cancer care. The Princess Margaret Cancer Centre implemented a digitally-based sc program in oncology, leveraging an e-referral system (cease) to screen all new ambulatory patients, provide tailored education and advice on quitting, and facilitate referrals.
Methods
We adopted the Framework for Managing eHealth Change to guide implementation of the sc program by integrating 6 key elements: governance and leadership, stakeholder engagement, communication, workflow analysis and integration, monitoring and evaluation, and training and education.
Results
Incorporating elements of the Framework, we used extensive stakeholder engagement and strategic partnerships to establish a sc program with organizational and provincial accountability. Existing electronic patient-reported assessments were changed to integrate cease. Clinic audits and staff engagement allowed for analysis of workflow, ongoing monitoring and evaluation that aided in establishing a communication strategy, and development of cancer-specific education for patients and health care providers. From April 2016 to March 2018, 22,137 new patients were eligible for screening. Among those new patients, 13,617 (62%) were screened, with 1382 (10%) being current smokers and 532 (4%) having recently quit (within 6 months). Of the current smokers and those who had recently quit, all were advised to quit or to stay smoke-free, and 380 (20%) accepted referral to a sc counselling service.
Conclusions
Here, we provide a comprehensive practice blueprint for the implementation of digitally based sc programs as a standard of care within comprehensive cancer centres with high patient volumes.
Identifiants
pubmed: 31896934
doi: 10.3747/co.26.5201
pii: conc-26-361
pmc: PMC6927783
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
361-368Informations de copyright
2019 Multimed Inc.
Déclaration de conflit d'intérêts
CONFLICT OF INTEREST DISCLOSURES We have read and understood Current Oncology’s policy on disclosing conflicts of interest, and we declare that we have none.
Références
J Cancer Educ. 2018 Feb;33(1):7-11
pubmed: 27075196
Can Fam Physician. 2014 Jul;60(7):e362-71
pubmed: 25022655
BMJ. 2006 May 20;332(7551):1207-10
pubmed: 16710002
Springerplus. 2016 Jul 20;5(1):1136
pubmed: 27504234
JAMA Intern Med. 2013 Mar 25;173(6):458-64
pubmed: 23440173
Addiction. 2015 Mar;110(3):381-6
pubmed: 25323093
Addict Behav. 2011 Jan-Feb;36(1-2):144-7
pubmed: 20869812
J Cancer Educ. 2019 May 22;:null
pubmed: 31119706
J Clin Oncol. 2014 Feb 20;32(6):564-70
pubmed: 24419133
J Cancer Educ. 2014 Jun;29(2):304-10
pubmed: 24420003
BMC Fam Pract. 2009 Dec 17;10:81
pubmed: 20017930
Int J High Risk Behav Addict. 2015 Mar 20;4(1):e20939
pubmed: 25883917
Int J Environ Res Public Health. 2009 Mar;6(3):1095-106
pubmed: 19440435
Eur J Cardiovasc Prev Rehabil. 2011 Apr;18(2):334-41
pubmed: 21450679
BMC Cancer. 2017 May 19;17(1):348
pubmed: 28526000
J Cancer Surviv. 2016 Apr;10(2):312-9
pubmed: 26298019
Acad Med. 2006 Mar;81(3):207-12
pubmed: 16501260
BMJ. 2004 Jun 19;328(7454):1470
pubmed: 15194599
Health Educ Res. 2009 Apr;24(2):292-305
pubmed: 18469319
J Int Assoc Provid AIDS Care. 2017 Sep/Oct;16(5):467-474
pubmed: 28578610
Br J Gen Pract. 2009 Sep;59(566):682-90
pubmed: 19674514
J Med Internet Res. 2019 Apr 09;21(4):e11735
pubmed: 30964445
Ann Intern Med. 2006 May 16;144(10):742-52
pubmed: 16702590
Mil Med. 2006 Jan;171(1):80-7
pubmed: 16532880
Curr Oncol. 2016 Aug;23(4):241-9
pubmed: 27536174
J Clin Oncol. 2013 Sep 1;31(25):3147-57
pubmed: 23897958
Int J Cancer. 2013 Jan 15;132(2):401-10
pubmed: 22539012
Oncologist. 2012;17(3):455-62
pubmed: 22334454
Eur J Gen Pract. 2015 Jun;21(2):111-7
pubmed: 25649048